Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma: Hypotheses based on two prospective phase II trials

Strahlentherapie und Onkologie

Volumn 189, Issue 11, 2013, Pages 926-931

  Balducci, M ^a   Fiorentino, A ^b   De Bonis, P ^a   Chiesa, S ^a   Mangiola, A ^a   Mattiucci, G C ^a   D'Agostino, G R ^a   Frascino, V ^a   Mantini, G ^a   Alitto, A R ^a   Colosimo, C ^a   Anile, C ^a   Valentini, V ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

Chemotherapy; Outcome; Radiotherapy; Survival; Toxicity

Indexed keywords

ANTICONVULSIVE AGENT; DNA METHYLTRANSFERASE; GADOLINIUM; SEROTONIN 3 ANTAGONIST; STEROID; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE II AS TOPIC; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; GLIOBLASTOMA; HUMANS; ITALY; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887251684     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0410-6     Document Type: Article

References (28)

1. Asthagiri AR, Pouratian N, Sherman J et al (2007) Advances in brain tumor surgery. Neurol Clin 25:975-1003
2. Athanassiou H, Sinodinou M, Maragoudakis E et al (2005) Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 23(10):2372-2377
3. Balducci M, Apicella G, Manfrida S et al (2010) Single-arm phase ii study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high grade gliomas. Strahlenther Onkol 186(10):558-564
4. Balducci M, Chiesa S, Diletto B et al (2012) Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study. Neuro Oncol 14(1):79-86
5. Balducci M, D'Agostino GR, Manfrida S et al (2010) Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study. J Neuroncol 97(1):95-100
6. Beauchesne P, Bernier V, Carnin C et al (2010) Prolonged survival for patients with newly diagnosed, inoperable gliobastoma with 3-times daily ultra fractionated radiation therapy. Neuro Oncol 12(6):595-602
7. Chalmers AJ, Ruff EM, Martindale C et al (2009) Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int J Radiat Oncol Biol Phys 75(5):1511-1519
8. Combs SE, Wagner J, Bischof M et al (2008) Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. Int J Radiat Oncol Biol Phys 71:999-1005
9. Curran WJ Jr, Scott CB, Horton J et al (1993) Recursive portioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710
10. Fiorentino A, Caivano R, Pedicini P, Fusco V (2013) Clinical target volume definition for glioblastoma treatment planning: magnetic resonance imaging and computed tomography. Clin Transl Oncol doi:10.1007/s12094-012-0992-y
11. Friedman HS, McLendon RE, Kerby T et al (1998) DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 16:3851-3857
12. Hainsworth JD, Ervin T, Friedman E et al (2010) Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme. Cancer 116(15):3663-3669
13. Hirose Y, Berger MS, Pieper RO (2001) P53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 61:1957-1963
14. Kesari S, Advani SJ, Lawson JD et al (2011) DNA damage response and repair: insights into strategies for radiation sensitization of gliomas. Future Oncol 7(11):1335-1346
15. Kocher M, Frommolt P, Borberg SK et al (2008) Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. Strahlenther Onkol 184:572-579
16. Kocher M, Kunze S, Eich HT et al (2005) Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol 181:157-163
17. Lanzetta G, Campanella C, Rozzi A et al (2003) Temozolomide in radio-chemotherapy combined treatment for newly diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 23:5159-5164
18. Mancuso S, Smaniotto D, Benedetti-Panici PL et al (2000) Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 78:324-328
19. Morganti AG, Balducci M, Salvati M et al (2010) A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. Int J Radiat Oncol Biol Phys 77(1):92-97
20. RoldanUgoiti GB, Singh AD, Easaw JC (2012) Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma. J Neuroncol 108(1):173-177
21. Simpson JR, Horton J, Scott C et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26:239-244
22. Sridhar T, Gore A, Boiangiu I et al (2009) Concomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: a retrospective study. Clin Oncol (R Coll Radiol) 21:19-22
23. Steward LA (2002) Chemotherapy in adult high grade glioma: a systematic review and metanalysis of individual patient data from 12 randomized trials. Lancet 359:1011-1018
24. Stupp R, Hegi ME, Gilbert MR, Charkravarti A (2007) Chemo-radiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25(26):4127-4136
25. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459-466
26. Stupp R, Mason WP, Van der Bent M et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblatoma. N Engl J Med 352(10):987-996
27. Valentini V, Coco C, Cellini N et al (1999) Preoperative chemoradiation with cisplatin and 5-fluorouracil for extra peritoneal T3 rectal cancer: acute toxicity tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys 45:1175-1184
28. Wedge SR, Porteous JK, Glaser MG et al (1997) In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs 8:92-97